TP53 and cancer: However, the mutation profiles are diverse across cancer types, with TP53 mutations being highly prevalent and observed in 81% of the cancer types, while well-known drivers such as BRAF, APC, and PTEN were distinctly associated with skin, large intestine, and endometrial cancers, respectively.